Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Ann Oncol 2019; (doi:10.1093/annonc/mdz117) In the original article, the Figure 1 caption contained an erroneous sentence. It has now been corrected to read: ‘Cumulative overall mortality and lung cancer mortality, by arm over 10 years of follow-up.’ The Publisher apologizes for the error. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacyAnnals of OncologyVol. 30Issue 7PreviewThe National Lung Screening Trial showed that lung cancer (LC) screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We evaluated the benefit of prolonged LDCT screening beyond 5 years, and its impact on overall and LC specific mortality at 10 years. Full-Text PDF Open Access